Aarti Pharmalabs
Aarti Pharmalabs Share Price Chart
Aarti Pharmalabs last traded at ₹879.50 (2026-10-13). Over the past month the stock moved +6.1%, three months the stock moved +26.6%, year the stock moved +5.8%. Its closing range over 52 weeks is ₹608.85 – ₹980.00, with the latest close 10.3% below the high.
Closing prices up to 2026-10-13.
About Aarti Pharmalabs
Incorporated in 2019, Aarti Pharmalabs Ltd is a manufacturer of Pharmaceuticals and Nutraceuticals[1]
Business Overview:[1] Aarti Pharmalabs Ltd, formerly known as Aarti Organics, was a Wholly Owned Subsidiary of Aarti Industries Limited. It got demerged in Oct'22 into a separately listed entity. Currently, the company is an internationally recognized manufacturer of generic API & Intermediates, Xanthine derivatives, and offers CDMO /CMO services. The company has 6 manufacturing plants and 3 R&D centres.
Fundamentals
Quarterly Results
In the latest quarter (Jun 2026), Aarti Pharmalabs reported sales of ₹536.00 crore (+38.9%) and net profit of ₹76.00 crore (+52.0%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 536.00 | 136.00 | 25.00 | 76.00 | 8.40 |
| Mar 2026 | 583.00 | 113.00 | 19.00 | 61.00 | 6.74 |
| Dec 2025 | 432.00 | 102.00 | 24.00 | 48.00 | 5.29 |
| Sep 2025 | 418.00 | 74.00 | 18.00 | 28.00 | 3.08 |
| Jun 2025 | 386.00 | 93.00 | 24.00 | 50.00 | 5.46 |
| Mar 2025 | 564.00 | 146.00 | 26.00 | 88.00 | 9.75 |
| Dec 2024 | 538.00 | 129.00 | 24.00 | 74.00 | 8.16 |
| Sep 2024 | 458.00 | 94.00 | 20.00 | 55.00 | 6.03 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +4.1% | +19.8% | +11.5% | -30.5% | -8.7% | -19.7% | +3.4% | +38.9% |
| Operating profit growth | +6.8% | +34.4% | +23.7% | -3.1% | -21.3% | -20.9% | -22.6% | +46.2% |
| Net profit growth | +5.8% | +39.6% | +35.4% | -9.1% | -49.1% | -35.1% | -30.7% | +52.0% |
| EPS growth | +5.4% | +40.2% | +35.4% | -10.8% | -48.9% | -35.2% | -30.9% | +53.8% |
| OPM % | 20.0% | 24.0% | 26.0% | 24.0% | 18.0% | 24.0% | 19.0% | 25.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Annual Financials
In the latest year (Mar 2026), Aarti Pharmalabs reported sales of ₹1,819.00 crore (-14.0%) and net profit of ₹175.00 crore (-35.7%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 1,819 | 369.00 | 20.00 | 175.00 | 19.27 |
| Mar 2025 | 2,115 | 464.00 | 22.00 | 272.00 | 30.05 |
| Mar 2024 | 1,853 | 386.00 | 21.00 | 217.00 | 23.93 |
| Mar 2023 | 1,945 | 342.00 | 18.00 | 193.00 | 21.35 |
| Mar 2022 | 1,200 | 207.00 | 17.00 | 122.00 | – |
| Mar 2021 | 0.00 | 0.00 | – | 0.00 | – |
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Sales growth | – | +62.1% | -4.7% | +14.1% | -14.0% |
| Operating profit growth | – | +65.2% | +12.9% | +20.2% | -20.5% |
| Net profit growth | – | +58.2% | +12.4% | +25.3% | -35.7% |
| EPS growth | – | – | +12.1% | +25.6% | -35.9% |
| OPM % | 17.0% | 18.0% | 21.0% | 22.0% | 20.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Shareholding
AI Analysis
No AI analysis generated yet for Aarti Pharmalabs.
Get Free AI Stock Analysis FREE →Latest News
-
Aarti Pharmalabs Bull Case Target Achieved
-
Kwality Pharma, Aarti Pharmalabs, Universal Cables hit 20% upper circuits - Business Standard
-
Aarti Pharmalabs hits the roof after Q1 PAT rises 65% YoY - Business Standard
-
Aarti Pharmalabs consolidated net profit rises 53.82% in the June 2026 quarter - business-standard.com
-
Aarti Pharmalabs surges on inaugurating additional manufacturing block at Tarapur Unit 5
-
Aarti Pharmalabs inaugurates additional manufacturing block at Tarapur Unit 5
Frequently Asked Questions
What is the share price of Aarti Pharmalabs today?
Aarti Pharmalabs shares were last quoted at ₹879.50 (+2.8% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
What is the P/E ratio of Aarti Pharmalabs?
Aarti Pharmalabs has a price-to-earnings (P/E) ratio of 39.94 and a price-to-book (P/B) ratio of 3.88. The industry P/E is 53.33.
What is the 52-week high and low of Aarti Pharmalabs?
The 52-week high of Aarti Pharmalabs is ₹962.00 and the 52-week low is ₹583.85.
What is the market cap of Aarti Pharmalabs?
The market capitalisation of Aarti Pharmalabs is about ₹8,514.38 crore.
How did Aarti Pharmalabs perform in its latest quarterly results?
In the latest quarter (Jun 2026), Aarti Pharmalabs reported sales of ₹536.00 crore (+38.9%) and net profit of ₹76.00 crore (+52.0%), compared with the same quarter last year.
Is Aarti Pharmalabs a good stock to buy?
This page is for information and is not investment advice. As per the data shown here, Aarti Pharmalabs has a 3-year ROE of 12.00%, 3-year profit growth of -3.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
What is the promoter holding in Aarti Pharmalabs?
Promoters hold about 42.86% of Aarti Pharmalabs.
Which sector does Aarti Pharmalabs belong to?
Aarti Pharmalabs belongs to the Medical Equipment/Supplies/Accessories sector.
Other Medical Equipment/Supplies/Accessories stocks
- Poly Medicure
- Indegene
- Molbio Diagnostics
- Q-Line Biotech
- Hemant Surgical Industries
- Prevest Denpro
- QMS Medical Allied Services
- Nureca
All Medical Equipment/Supplies/Accessories stocks · Browse all stocks A–Z